Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
Mallardo D, Simeone E, Festino L, Tuffanelli M, Vanella V, Trojaniello C, Vitale MG, Ottaviano M, Capone M, Madonna G, Sparano F, Cioli E, Scarpato L, Palla M, Di Trolio R, Meinardi P, Caracò C, Ferrara G, Muto P, Cavalcanti E, Ascierto PA. Mallardo D, et al. Among authors: meinardi p. J Transl Med. 2023 Feb 23;21(1):140. doi: 10.1186/s12967-023-03971-5. J Transl Med. 2023. PMID: 36823670 Free PMC article.
Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map.
Salazar J, Bracchiglione J, Acosta-Dighero R, Meza N, Meade AG, Quintana MJ, Requeijo C, Rodríguez-Grijalva G, Santero M, Selva A, Solà I, Bonfill X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Salazar J, et al. Support Care Cancer. 2023 Jan 9;31(2):100. doi: 10.1007/s00520-022-07564-8. Support Care Cancer. 2023. PMID: 36622453 Free PMC article. Review.
Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review.
Salazar J, Bracchiglione J, Savall-Esteve O, Antequera A, Bottaro-Parra D, Gutiérrez-Valencia M, Martínez-Peralta S, Pericay C, Tibau A, Bonfill X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group. Salazar J, et al. BMC Cancer. 2023 Aug 12;23(1):748. doi: 10.1186/s12885-023-11207-4. BMC Cancer. 2023. PMID: 37573294 Free PMC article.
Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
Mallardo D, Sparano F, Vitale MG, Trojaniello C, Fordellone M, Cioli E, Esposito A, Festino L, Mallardo M, Vanella V, Facchini BA, De Filippi R, Meinardi P, Ottaviano M, Caracò C, Simeone E, Ascierto PA. Mallardo D, et al. Among authors: meinardi p. Cancer Immunol Immunother. 2024 Jun 8;73(8):160. doi: 10.1007/s00262-024-03728-z. Cancer Immunol Immunother. 2024. PMID: 38850335 Free PMC article.
Utilising systematic reviews to assess potential overtreatment and claim for better evidence-based research: an analysis of anticancer drugs versus supportive care in advanced esophageal cancer.
Santero M, Meade AG, Selva A, Savall-Esteve O, Bracchiglione J, Macías I, Leache L, Cerdà P, Bonfill Cosp X; Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC-Study) Research Group. Santero M, et al. Syst Rev. 2024 Jul 18;13(1):186. doi: 10.1186/s13643-024-02594-1. Syst Rev. 2024. PMID: 39026378 Free PMC article.